PharmaBoardroom

“Canada Needs to do Better in Supporting Innovative…

Brian Hilberdink, President of Novo Nordisk Canada, calls for the Canadian government to encourage and invest in innovative biopharmaceutical…

Company Profile: GW Pharmaceuticals

Founded in 1998, GW Pharmaceuticals is a British biopharmaceutical company, best known for being the only company with a license to cultivate cannabis…

Pierre-Claude Fumoleau – General Manager, AbbVie France

Abbvie France’s Pierre-Claude Fumoleau outlines his strategic priorities for the affiliate, AbbVie’s unique corporate culture and ethos, and how…

Seok Joo Lee – CEO, ISU Abxis, South Korea

ISU Abxis, a subsidiary of the ISU conglomerate, is a biotech company with a focus on orphan drugs and rare disease. CEO Seok Joo Lee explains the…

Olivier Samama – General Manager, France & Head of…

Biotest’s Olivier Samama outlines the changes that the takeover of the company has had on the French affiliate, the country’s plasma market and…

Weidong Zhong – Founder & CEO, Terns Pharmaceuticals,…

Terns Pharmaceuticals is developing innovative drugs for the treatment of NASH and liver disease. It has established a diverse product pipeline with…

Jane Griffiths – Global Head, Actelion

Jane Griffiths, global head of Actelion – acquired in 2017 by Johnson & Johnson – discusses her priorities heading up an iconic rare…

María Jesús Lamas – Director & César Hernández…

María Jesús Lamas, director and César Hernández García, head of medicines for human use at the Spanish Agency of Medicine and Health Products…

Bong Gil Nam – Chairman & Owner, Pharmbio Korea

Bong Gil Nam, chairman and owner of Pharmbio Korea, offers his insights on his company’s importance in differentiating itself from the generic…

Han-Oh Park – President, Founder and CEO, Bioneer, South…

Bioneer, founded in 1992, lays claim to be Korea’s oldest biotechnology company. President, founder and CEO, Dr Han-Oh Park introduces the…

French Government Signs Strategic Contract for Healthcare and…

On February 4 in Paris, Minister of Health and Solidarity Agnès Buzyn, Minister of Higher Education, Research and Innovation Frédérique Vidal,…

5 Biotechs to Watch in China

Even though China’s pharmaceutical sector remains largely generics-based, the Middle Kingdom’s biotechnology scene has been flourishing in recent…

Tagged with BI